Department of Dermatology, University of Miami, The Cosmetic Bootcamp, 1500 North Dixie Highway, Suite 303, West Palm Beach, FL 33401, USA.
Dermatol Clin. 2009 Oct;27(4):427-32, v. doi: 10.1016/j.det.2009.08.011.
Until recently, the use of dermal fillers was limited in the United States by the small number of products approved by the Food and Drug Administration. The products now approved for use in the United States have opened up the range of possibilities for combinations of products that are synergistic in their effects. Combinations of products may be discussed in temporal or anatomic relationships. Temporal combinations refer to the use of different fillers at different times, whereas anatomic combinations refer to the use of different fillers in different parts of the face. Before discussing how the various fillers may be used in combination, it is worthwhile to consider their use in isolation. Soft-tissue augmentation products under consideration in the present article include the hyaluronic acids (HA), poly L lactic acid (PLLA), calcium hydroxylapatite (CAHA), porcine collagen, and silicone.
直到最近，由于食品和药物管理局批准的产品数量有限，美国在使用真皮填充剂方面受到限制。现在在美国获准使用的产品为产品的组合效果开辟了更多的可能性。产品的组合可以按照时间或解剖关系来讨论。时间组合是指在不同时间使用不同的填充物，而解剖组合是指在面部的不同部位使用不同的填充物。在讨论各种填充物如何组合使用之前，值得考虑它们单独使用的情况。本文中考虑的软组织填充产品包括透明质酸 (HA)、聚左旋乳酸 (PLLA)、羟基磷灰石钙 (CAHA)、猪胶原蛋白和硅酮。
